Zdenek Hel
Basic Research Laboratory
National Cancer Institute
41/D804
Bethesda
USA
Name/email consistency: high
- A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine. Hel, Z., Johnson, J.M., Tryniszewska, E., Tsai, W.P., Harrod, R., Fullen, J., Tartaglia, J., Franchini, G. Vaccine (2002)